Okra in Diabetes

Early Phase 1

Conditions: Diabet.
Diseases of the circulatory system
I00-I99

Registration Number: IRCT20190701044064N1

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 60

Inclusion Criteria

Taking Oral Anti Diabetic Medicine
No Pregnancy
Lack of Alcohol
Do not Take Anti Hypertensive Medication
No Smoking
Not Taking Herbal Supplement to Control Blood Glucose
Non Lactation in Women
Not Getting Kidney Disease, Especially Diabetic Nephropathy

Exclusion Criteria

Okra Sensitivity
Get Pregnant
Unwillingness to Cooperate

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood glucose. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.;Serum LDL-C. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.;HDL-C Serum. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.;TG Serum. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.;Total cholesterol. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.;Hemoglobin A1c. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical method.

Secondary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: The beginning and the end of the study. Method of measurement: Blood pressure monitor.;Weight. Timepoint: The beginning and the end of the study. Method of measurement: digital Balance.;Age. Timepoint: Beginning of study. Method of measurement: questionnaire.;Sex. Timepoint: Beginning of study. Method of measurement: questionnaire.